GLP-1 receptor agonist 9
GLP-1 receptor agonist 9 is a GLP-1 receptor agonist, example 7, extracted from WO2020234726 A1[1].
Product Specifications
CAS Number
[2401892-71-3]
UNSPSC
12352005
Target
GCGR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/glp-1-receptor-agonist-9.html
Purity
99.70
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@]1(C2=C(C=C(C=C2)Cl)F)OC3=C(C4CCN(CC4)CC(N(C5=C6)C[C@@H]7CCO7)=NC5=CC=C6C(O)=O)C=CC=C3O1
Molecular Formula
C32H31ClFN3O5
Molecular Weight
592.06
References & Citations
[1]Gary E. Aspnes, et al. Combinaisons comprenant du benzodioxol en tant qu'agonistes de glp-1r destinées à être utilisées dans le traitement de la nash/nafld et de maladies associées. Patent WO2020234726 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6383613-01 0.1 mL
KIR2DS3 (Killer Cell Immunoglobulin-like Receptor 2DS3, MHC Class I NK Cell Receptor, Natural Killer-associated Transcript 7, NKAT-7, NKAT7) (MaxLight 405)
Ask
View Details 
MBS6383613-02 5x 0.1 mL
KIR2DS3 (Killer Cell Immunoglobulin-like Receptor 2DS3, MHC Class I NK Cell Receptor, Natural Killer-associated Transcript 7, NKAT-7, NKAT7) (MaxLight 405)
Ask
View Details